We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MXIM
276
DELISTED
Maxim Integrated Products
MXIM
| $17.9M | 0.05% |
291,677
+22,610
| +8% | +$1.32M |
|
277
Diageo
DEO
$46.2B
| $17.9M | 0.05% |
106,046
+1,489
| +1% | +$242K |
|
278
Trane Technologies
TT
$106B
| $17.6M | 0.05% |
132,550
-7,578
| -5% | -$960K |
|
279
Dollar Tree
DLTR
$23.1B
| $17.1M | 0.04% |
182,349
-8,144
| -4% | -$855K |
|
280
FedEx
FDX
$74.4B
| $17.1M | 0.04% |
113,211
-9,250
| -8% | -$1.43M |
|
281
Boston Scientific
BSX
$65.8B
| $17M | 0.04% |
376,176
+25,355
| +7% | +$1.06M |
|
|
IBDC
282
DELISTED
iShares iBonds Mar 2020 Term Corporate ETF
IBDC
| $17M | 0.04% |
651,064
+70,975
| +12% | +$1.85M |
|
283
State Street Industrial Select Sector SPDR ETF
XLI
$33.8B
| $16.8M | 0.04% |
206,640
-3,412
| -2% | -$272K |
|
284
Aflac
AFL
$63.9B
| $16.8M | 0.04% |
318,004
-30,738
| -9% | -$1.63M |
|
285
AB InBev
BUD
$158B
| $16.8M | 0.04% |
204,961
-4,101
| -2% | -$342K |
|
|
IBDN
286
DELISTED
iShares iBonds Dec 2022 Term Corporate ETF
IBDN
| $16.8M | 0.04% |
662,826
+25,878
| +4% | +$655K |
|
287
Alibaba
BABA
$269B
| $16.7M | 0.04% |
78,883
-1,371
| -2% | -$257K |
|
288
Sumitomo Mitsui Financial
SMFG
$167B
| $16.7M | 0.04% |
2,257,083
-858
| -0% | -$6.17K |
|
289
Humana
HUM
$46.8B
| $16.7M | 0.04% |
45,501
+702
| +2% | +$223K |
|
290
Dominion Energy
D
$62.6B
| $16.5M | 0.04% |
199,010
-2,955
| -1% | -$241K |
|
291
Expeditors International
EXPD
$23B
| $16.4M | 0.04% |
210,761
-715
| -0.3% | -$53.6K |
|
292
Rockwell Automation
ROK
$51.5B
| $16.4M | 0.04% |
81,096
+2,258
| +3% | +$418K |
|
293
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.83B
| $16.3M | 0.04% |
384,034
+23,468
| +7% | +$966K |
|
|
IBMI
294
DELISTED
iShares iBonds Sep 2020 Term Muni Bond ETF
IBMI
| $16.2M | 0.04% |
633,662
-19,108
| -3% | -$488K |
|
295
Schwab International Small-Cap Equity ETF
SCHC
$5.35B
| $16.2M | 0.04% |
466,508
+15,313
| +3% | +$511K |
|
296
iShares MSCI USA Momentum Factor ETF
MTUM
$25.5B
| $16M | 0.04% |
127,741
-39,628
| -24% | -$4.81M |
|
297
Republic Services
RSG
$66.8B
| $15.6M | 0.04% |
173,880
+116
| +0.1% | +$10.1K |
|
298
NVIDIA
NVDA
$5.01T
| $15.5M | 0.04% |
2,628,360
-134,120
| -5% | -$698K |
|
|
RDS.A
299
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $15.4M | 0.04% |
261,708
-44,833
| -15% | -$2.62M |
|
300
State Street Energy Select Sector SPDR ETF
XLE
$39.4B
| $15.1M | 0.04% |
502,904
-58,696
| -10% | -$1.74M |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.